Publication | Closed Access

Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone

Surgical OncologyMedicineCancer ManagementPathologyImmune Checkpoint InhibitorSurgeryPrimary ChemotherapyMetronomic ChemotherapyCancer TreatmentElevated Tumor MarkersOncologyEffective TherapyTumor MicroenvironmentCancer Research